載入...
The Utility of Cerebral Blood Flow as a Biomarker of Preclinical Alzheimer’s Disease
There is accumulating evidence suggesting that changes in brain perfusion are present long before the clinical symptoms of Alzheimer’s disease (AD), perhaps even before amyloid-β accumulation or brain atrophy. This evidence, consistent with the vascular hypothesis of AD, implicates cerebral blood fl...
Na minha lista:
| 發表在: | Cell Mol Neurobiol |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2016
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5278904/ https://ncbi.nlm.nih.gov/pubmed/26898552 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10571-015-0261-z |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|